Purchase Order N6817119P6002

This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...

<p>This is a Firm Fixed Price delivery order contract awarded by the Defense Health Agency to Immucor Italia S.P.A., a for-profit organization, for the PANOSCREEN I, II, and III products. The contract has a potential value of $7,639.72 and a completion date of October 27, 2023. The contract is not associated with a set-aside program.</p>

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...

This federal contract award, valued at $244,758.17, was issued by the Defense Health Agency to Immucor Inc., a manufacturer of goods, for the delivery of CAP R RS (3) 5 PLATE DOMESTIC. The contract is a firm fixed-price purchase order without a set-aside designation, with a period of performance through May 31, 2024. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The company has a history...

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract, valued at $535,165.00, is for the delivery of two blood bank automated analyzers to the William Beaumont Army Medical Center in El Paso, Texas. The contract term is from October 1, 2023, through September 30, 2028. This procurement...

This is a delivery order contract awarded by the Pacific Air Forces, a Defense agency, to Immucor Inc., a for-profit manufacturer, for the provision of medical and surgical instruments, equipment, and supplies. The contract has a not-to-exceed ceiling value of $83,972.72 and was awarded on a firm-fixed price basis. The contract was not set aside for any specific business type. The award appears to be issued under an existing indefinite delivery vehicle that Immucor holds, facilitating the...

This is a Blanket Purchase Agreement (BPA) call for a firm fixed price contract awarded by the Defense Health Agency to Immucor Inc., a manufacturer of in vitro diagnostic products related to blood transfusion and transplantation compatibility testing. The contract is for the delivery of 66813 CAP RDY SCREEN 3 items, with a ceiling value of $243,513.50 and a period of performance ending on September 30, 2017. The contract was awarded on October 11, 2016 and does not have a set-aside designation....

This federal contract award, N6809622P0004, was issued by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of goods, for the provision of IMMUCOR REAGENTS. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $80,569.98 and a completion date of September 27, 2022. No set-aside was used for this award. Immucor Inc. is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing....

This is a $27,460.00 Firm Fixed Price purchase order awarded by the Defense Health Agency (DHA) to Immucor Inc., a manufacturer of in vitro diagnostic supplies. The contract is for the delivery of 111801 HB 301 MICROCUVETTS, which are specialized disposable equipment used in blood typing and compatibility testing procedures. Immucor is a prime vendor to federal agencies, including the Department of Veterans Affairs and the Indian Health Service, for a range of blood banking and...